Study of oxidative stress in type 2 diabetic patients and its relationship with glycated hemoglobin

Saudi Medical Journal

Volumn 29, Issue 4, 2008, Pages 503-506

  Goodarzi, Mohammad T ^a   Varmaziar, Liela ^b   Navidi, Ali A ^a   Parivar, Kazem ^b  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; HEMOGLOBIN A1C; MALONALDEHYDE; SUPEROXIDE DISMUTASE; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERGLYCEMIA; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; BLOOD; METABOLISM; MIDDLE AGED;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 46749150173     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Niedowicz DM, Daleke DL. The role of oxidative stress in diabetic complications. Cell Biochem Biophys 2005; 43: 289-330.
2. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, Tritschler H, Rosen P, Halliwell B, et al. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 1997; 40: 647-653.
3. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol 2003; 17: 24-38.
4. Valeri C, Pozzilli P, Leslie D. Glucose control in diabetes. Diabetes Metab Res Rev 2004; 20: S1-S8.
5. Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice. Cardiovasc Diabetol 2005; 4: 5.
6. Kedziora-Kornatowska K, Szram S, Kornatowski T, Szadujkis-Szadurski L, Kedziora J, Bartosz G. Effect of vitamin E and vitamin C supplementation of antioxidative state and renal glomerular basement membrane thickness in diabetic kidney. Nephron Exp Nephrol 2003; 95: 134-143.
7. Cinar M, Ulker S, Alper G, Evinc A. Effect of dietary vitamin E supplementation on vascular reactivity of thoracic aorta in streptozotocin-diabetic rats. Pharmacology 2001; 62: 56-64.
8. Rauscher FM, Sanders RA, Watkins JB 3rd. Effects of coenzyme Q10 treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001; 15: 41-46.
9. Mekinová D, Chorváthová V, Volkovová K, Staruchová M, Grancicová E, Klvanová J, et al. Effect of intake of exogenous vitamins C, E and beta-carotene on the antioxidative status in kidneys of rats with streptozotocin-induced diabetes. Nahrung 1995; 39: 257-261.
10. Maritim AC, Sanders RA, Watkins JB 3rd. Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem 2003; 14: 288-294.
11. Turk HM, Sevinc A, Camci C, Cigli A, Buyukberber S, Savli H, et al. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Acta Diabetol 2002; 39: 117-122.
12. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 2000; 26: 163-176.
13. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, et al. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 1995; 98: 469-475.
14. Mahboob M, Rahman MF, Grover P. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. Singapore Med J 2005; 46: 322-324.
15. Martín-Gallán P, Carrascosa A, Gussinyé M, Domínguez C. Biomarkersofdiabetes-associatedoxidativestressandantioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003; 34: 1563-1574.
16. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
17. McCord JM, Fridivich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049-6055.
18. Rodriguez-Martinez MA, Ruiz-Torres A. Homeostasis between lipid peroxidation and antioxidant enzyme activities in healthy human ageing. Mech Ageing Dev 1992; 66: 213-122.
19. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
20. Creager MA, Lüscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003; 108: 1527-1532.
21. Mooradian AD. Increased serum conjugated dienes in elderly diabetic patients. J Am Geriatric Soc 1991; 39: 571-574.
22. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, et al. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 1995; 98: 469-475.
23. Suckling KE, Jackson B. Animal models of human lipid metabolism. Prog Lipid Res 1993; 32: 1-24.
24. Freitas JP, Filipe PM, Rodrigo FG. Lipid peroxidation in type 2 normolipidemic diabetic patients. Diabetes Res Clin Pract 1997; 36: 71-75.
25. Losada M, Alio JL. Malondialdehyde serum concentration in type 1 diabetic with and without retinopathy. Doc Ophthalmol 1996-1997; 93: 223-229.
26. Kesavulu MM, Giri R, Kameswara Rao B, Apparao CH. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab 2000; 26: 387-392.
27. Kaji H, Kurasaki M, Ito K, Saito T, Saito K, Niioka T, et al. Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type 2 (non-insulin-dependent) diabetic women. Klin Wochenschr 1985; 63: 765-768.
28. Peuchant E, Delmas-Beauvieux MC, Couchouron A, Dubourg L, Thomas MJ, Perromat A, et al. Short-term insulin therapy and normoglycemia. Effects on erythrocyte lipid peroxidation in NIDDM patients. Diabetes Care 1997; 20: 202-207.
29. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci 1996; 90: 255-260.